Economic Evaluation of Everolimus versus Sorafenib for the Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line Sunitinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Economic Evaluation of Everolimus versus Sorafenib for the Treatment of Metastatic Renal Cell Carcinoma after Failure of First-Line Sunitinib

Published:2011-09 Issue:6 Volume:14 Page:846-851
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Casciano Roman,Chulikavit Maruit,Di Lorenzo Giuseppe,Liu Zhimei,Baladi Jean-Francois,Wang Xufang,Robertson Justin,Garrison Lou

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference42 articles.

1. Rising incidence of small renal masses: a need to reassess treatment effect;Hollingsworth;J Natl Cancer Inst,2006

2. Renal-cell carcinoma;Motzer;N Engl J Med,1996

3. Renal cell carcinoma guideline;Ljungberg;Eur Urol,2007

4. The burden of illness associated with renal cell carcinoma in the United States;Lang;Urol Oncol,2007

5. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review;Gupta;Cancer Treat Rev,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer;Gynecologic Oncology;2024-04

2. Cost-effectiveness analysis of 7 treatments in metastatic hormone-sensitive prostate cancer: a public-payer perspective;JNCI: Journal of the National Cancer Institute;2023-07-12

3. Current Issues in the Management of Patients With Newly Diagnosed Advanced-Stage High-Grade Serous Carcinoma of the Ovary;JCO Oncology Practice;2023-03

4. Cost-Effectiveness Analysis of Six Immunotherapy-Based Regimens and Sunitinib in Metastatic Renal Cell Carcinoma: A Public Payer Perspective;JCO Oncology Practice;2023-03

5. Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinoma;European Radiology;2022-11-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3